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Abstract
Introduction
Cancer is a set of diseases in which normal cells undergo 
neoplastic transformation through a series of incremental 
steps that occur under selective pressure. Any change can 
be critical to tipping the scales toward the progression to 
malignancy.(1,2) Cancer is a complex disease with genetic, 
environmental, clinical, and lifestyle factors, all of which 
contribute to tumor initiation until malignant progression.(3) 
In this review, we highlight that somehow cancer could be 
termed as an inflammatory disease, and how the nutrition by 
the time will impact as the pro and contra on carcinogenesis 
process, especially the red meat and processed meat versus 
some beneficial phytochemical on the contrary.
 Recent data appears to confirm that oxidative stress 
may have a big role in malignant transformation in primary 
tumors to augment their metastatic potential. A paper 
published in 2015 suggested the importance of increased 
production of reactive oxygen species (ROS) to enable 
and sustain a highly metastatic phenotype, although many 
opinions still debate for the controversial role of ROS and 
antioxidants in cancer.(4,5) Previously, cancer thought to 
be originated from cell autonomous defects (1), but now it 
become clear that a complex microenvironment engaged 
the cancer cell in stimulatory or inhibitory interactions 
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R E V I E W  A R T I C L E
BACKGROUND: Along with its increased prevalence, in the past decade, cancer had joined the list of chronic debilitating diseases. Nutrition 
become substantial aspects, due to its time-dependent 
effect to modulate inflammation thus trigger carcinogenic 
effects by altering the immune check point. Thus, nutrition 
contributes to the progression and therapeutic response of 
cancer, both in human or animal models.
CONTENT: Meat is well favored food with appreciable 
appealing. Due to its high nutritional values it plays a central 
role in human development. Meat or meat derivate are 
important sources of proteins, minerals and vitamins. Their 
nutritional importance is worth compare to their economic 
impact but recent publication of WHO has set the social 
alarm about the relationship between red and/or processed 
meat  consumption  and  cancer.  On  the  other  side,  some 
natural or biologic agents may inhibit or reverse tumor 
growth. Some phytochemical agents including curcumin, 
resveratrol, lycopene, folates and tea polyphenols clinically 
proved to tune the signaling pathways regulating cell 
proliferation and apoptosis in transformed cells, enhance 
the host immune system and sensitize malignant cells to 
cytotoxic agents.
SUMMARY:  Recent studies on chemopreventive agents 
involves a wide range of molecules, natural (plants, fruits 
and vegetables) or synthetic will provide better insights for 
cancer early pathogenesis, important end-point biomarker, 
and finally potential for reducing the burden of cancer.
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with stromal components. Chronic inflammation could 
consequence in arising cancer, when malignant cells escape 
from or suppress immunosurveillance mechanisms.(6) In 
other words, inflammation and immune process can either 
stimulate or restrain carcinogenesis and tumor progression, 
respectively.(7-10)
 Red meat contains high biological-value proteins and 
important micronutrients such as omega-3-polyunsaturated 
fatty acids, B vitamins, iron (both free iron and heme iron), 
and zinc. The fat content of red meat varies depending on 
animal species, age, sex, breed, and feed, and the cut of the 
meat. Meat processing, such as curing and smoking, can 
result in formation of carcinogenic chemicals, including 
N-nitroso-compounds (NOC) and polycyclic aromatic 
hydrocarbons (PAH). Cooking improves the digestibility 
and palatability of meat, but can also produce known or 
suspected carcinogens, including heterocyclic aromatic 
amines (HAA) and PAH. High-temperature cooking by pan- 
frying, grilling, or barbecuing generally produces the highest 
amounts of these chemicals.(11,12) The International 
Agency for Research on Cancer (IARC) assessed more than 
800 epidemiological studies that found the association of 
cancer with consumption of red meat or processed meat 
in many countries, from several continents, with diverse 
ethnicities and diets.(13) 
 Chemoprevention can be simply defined as using 
agents or compounds either natural or synthetic to inhibit 
tumorigenesis or tumor progression. The agents included 
here might perform their roles either by blocking cancer 
causing agents so that the DNA mutation will not be 
allowed, increasing the DNA repairing system or acting on 
cells with modified DNA, decreasing the cell cycle speed 
or interfere with events necessary for tumor spreading 
through metastasis. The classic mechanisms may involve 
free radical scavenging enzymes activation, chronic 
inflammation control, and specific signaling pathways 
downregulation. More recent understanding involving 
epigenetic aspects suggested several chemo preventive 
agents such as sulforaphane, green tea derived compounds, 
resveratrol, isoflavones, etc. Chemoprevention can give 
benefits on people with cancer or those without cancer but 
have a higher risk of developing it.(14-18)
Oxidative Stress, Inflammation and Cancer
promotion, survival, proliferation, invasion, angiogenesis, 
and metastasis (19,20), exemplified by many cases such as 
reflux esophagitis, gastritis, inflammatory bowel disease, 
silicosis-associated lung cancer, asbestosis-induced 
mesothelioma and various types of hepatitis induced by 
viruses, alcohol consumption or a Western-style diet (21). 
The carcinogenic effects of inflammation may be dependent 
on chronic stimulation of cellular turnover, which affect in 
increased stem-cell divisions, thus local mutagenic effects. 
The agent that cause inflammation itself can promote 
mutagenesis, enhanced by ROS production either as a side 
product of locally enhanced metabolism or are generated 
specifically by macrophages.(22) Nutrition now known 
to influence inflammation and immune response, promote 
the development of the dietary inflammatory index and 
immunonutrition as the term in epidemiological and 
clinical studies.(23-25) Figure 1 showed how qualitative 
and quantitative imbalances in food intake chronically 
predispose organisms, modulating a state of chronic 
inflammation in a manner dependent on or independent 
of the immune system, thus affecting to a time-dependent 
deterioration in function that culminates in the development 
and progression of cancer.
 Caspase-1 activation complexes (inflammasomes), as 
their name imply, play a critical role in autoinflammatory 
syndromes, refer to conditions featuring recurrent 
episodes of systemic inflammation without (known) 
pathogens, autoantibodies or antigen-specific T cells.(7-
9) Inflammasomes can contribute to tissue homeostasis, 
inflammation and immune responses to affect the formation, 
Figure 1. Relationships among nutrition, inflammation and 
immunity, and cancer.(25) (Adapted with permission from 
Springer Nature).
Almost every mechanism in carcinogenesis involving 
chronic inflammation, from cellular transformation, 
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progression and therapeutic response of cancer.(10) The 
contrasting roles of inflammasomes in the complex interplay 
between malignant cells and their niches operate at the 
cell-autonomous level. In inflammatory cells, caspase-1 
activation can eliminate malignant precursors through 
programmed cell death and sterile inflammation and 
carcinogenesis, but contrarily in antigen-presenting cells 
stimulate anticancer immune responses and the production 
of trophic factors for cancer cells and their stroma. The 
inhibition of inflammasomes or their products neutralization, 
mainly interleukin (IL)-1b and IL-18, showed profound 
effects on carcinogenesis and tumor progression.(10)
 Cancers derived from epithelial cells known as 
carcinomas while adenocarcinomas derived from epithelium 
in glandular tissues. They are heterogenous, consist not only 
cancer cells but also cancer-associated fibroblasts, different 
tumor-infiltrating immune cells, adipocytes, endothelial 
cells, pericytes and others. These cells secrete chemokines 
and cytokines (26,27), affect cancer cells directly or promote 
cancer-associated inflammation by inducing immune 
cell infiltration thus lead to tumor initiation, progression, 
metastasis, but also have a role in cancer treatment. One 
of the most frequent immune cells involved are myeloid 
cells, including immature myeloid cells, neutrophils and 
macrophages, utilized as a cellular source for inflammasomes 
activation and secreting IL-1β and IL-18.(28) The etiological 
link between tumorigenesis and the chronic inflammation 
have been well documented in gastrointestinal (GI) tract 
cancers, where Helicobacter pylori infection associated 
with chronic gastritis, and colorectal cancer frequently 
associated with inflammatory bowel disease.(10,26,29). As 
inflammatory mediators, inflammasomes and their products 
also proved to be associated with GI cancers.
 Oxidative stress mediated mechanisms in 
carcinogenesis in three stages: initiation, promotion, and 
progression. Oxidative stress leads to mutations in oncogenes 
and tumor-suppressor genes in the initiation stages.(30,31) 
The 8-Hydroxy-20-deoxyguanosine (8-OHdG) elevation 
usually measured to observe oxidative stress-associated 
DNA-adduct in precancerous and cancerous tissues or 
cancer cell lines compare to normal tissue.(32-36) The 
8-OHdG could induce GC to TA missense mutations, which 
will produce a transformed cell if they were escaping repair 
prior to DNA replication.(36) The formation of 8-OHdG 
DNA-adducts often related to tumor suppressor (TP53) 
and oncogene (KRAS) mutation observed in tobacco 
smoke-induced oxidative stress lungs.(37-39) Many 
clinical trials studying ROS and antioxidants in cancer 
showed controversial results, suggest that excessive ROS 
accumulation promotes severe cellular damage and triggers 
apoptosis including cancer cells, therefore cancer cells 
depend on an increased antioxidant capacity, which keeps 
ROS levels higher than in normal cells, but below a critical 
threshold able to maintain their viability. ROS limit distant 
metastasis: only cells with increased antioxidant capacity, 
or cells with adaptation to build up a powerful antioxidant 
response are able to succeed in their purpose to metastasize.
(4,5,40) Indeed, cancer initiation and progression has been 
linked to oxidative stress by increasing DNA mutations 
or inducing DNA damage, genome instability, and cell 
proliferation.(31)
 The transcription factor nuclear factor erythroid 
2 (NF-E2)-related factor 2 (Nrf2) belongs to the Cap ‘N’ 
Collar (CNC) family that contains a conserved basic leucine 
zipper (bZIP) structure. Nrf2 mainly function to activate the 
cellular antioxidant response to combat the harmful effects 
of extrinsic and intrinsic threats, such as xenobiotics and 
oxidative stress, make it traditionally regarded as the cell’s 
main defense mechanism for survival, as seen in Figure 
2. The dissociated Keap1 is ubiquitinated for proteasomal 
degradation, inducing Nrf2 translocates to the nucleus 
and binds to Maf to initiate transcription of antioxidant/
detoxification genes such as superoxide dismutase (SOD), 
heme oxygenase-1 (HMOX-1), nicotinamide adenine 
dinucleotide phosphate (NADPH): quinone oxidoreductase 1 
(NQO1), and glutathione-s-transferases (GSTs) and combat 
the oxidative stress. Nrf2 defense response activation has 
been shown to protect against neurodegenerative diseases, 
aging, diabetes, photo-oxidative stress, cardiovascular 
disease, inflammation, pulmonary fibrosis, acute pulmonary 
injury, cancer, also against chemical carcinogen-induced 
tumor formation in the stomach, bladder and skin.(41-46) 
Contrarily, mice with single-nucleotide polymorphism 
(SNP) that reduced expression of Nrf2 are more susceptible 
to hyperoxia-induced lung damage, supporting the idea of 
protective role of Nrf2 against ROS and DNA damage in 
cells.(47-49)
 Nrf2 activation has been noticed to protect against a 
variety of toxicants and diseases, yet its prolonged activation 
affecting on several types of cancer progression such as lung, 
breast, head and neck, ovarian, and endometrial carcinomas 
with clinically poor prognosis (50-52), partly due to Nrf2’s 
ability to enhance cancer cell proliferation and promote 
chemoresistance and radioresistance, explaining why Nrf2 
expression is induced during the course of drug resistance.
(46) Oxidative stress can activate transcription factors such 
as nuclear factor-kappaB (NF-κB), activator protein 1 (AP-
1), p53, hypoxia-inducible factors (HIF)-1α, peroxisome 
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Figure 2. Activation of Nrf2 in response to mild oxidative stress.(39) (Adapted with permission from Elsevier).
proliferator-activated receptors (PPAR)-γ, β-catenin/Wnt, 
and Nrf2, which lead to the expression of more than 500 
genes including those for growth factors, inflammatory 
cytokines, chemokines, cell cycle regulatory molecules, and 
anti-inflammatory molecules. Overall, we could suggest that 
oxidative stress via chronic inflammation are closely link 
to transform normal cell to tumor cell, tumor cell survival, 
proliferation, chemoresistance, radioresistance, invasion, 
angiogenesis and stem cell survival.(31)
 Obesity is a risk factor for cancer development and 
is associated with poor prognosis in multiple tumor types. 
The positive energy balance linked with obesity induces 
a variety of systemic changes including altered levels 
of insulin, insulin-like growth factor (IGF)-1, leptin, 
adiponectin, steroid hormones, and cytokines. Each of these 
factors alters the nutritional milieu and has the potential 
to create an  environment that favors tumor initiation and 
progression.(2)
Consumption of Red and Processed Meat, and Cancer
Red meat is defined as flesh from mammals (pork, beef, lamb, 
veal, etc.), red when it is raw, due to a higher percentage 
of red muscle fiber than white.(53) Processed meat regards 
as preserved and flavored meat using methods such as 
salting, smoking, fermentation and curing.(13) Previous 
epidemiological and experimental studies associate red or 
processed meat consumption to colorectal carcinoma, and 
increased incidence of many other carcinomas such as 
oesophageal, gastric, breast, pancreas and lung.(54-56) The 
International IARC confirmed a sufficient evidence for an 
association between colorectal carcinoma and consumption 
of processed meat.(13) The 2007 panel also concluded that 
cancers of the esophagus, lung, pancreas, prostate, stomach, 
and endometrium may be linked to red and processed meat 
consumption; however, the evidence at the time was limited 
and inconsistent.(53)
 GI cancers has a sporadic pattern, and arise in 
individual by cause of environmental rather than hereditary 
risk factors, with diet as the strongest contributor.(57) A 
high-fat diet increases bile acid secretion that is transformed 
by colonic microbiota into secondary bile acid with 
genotoxic properties of DNA damage due to ROS and 
nitric oxide synthase (NOS).(58,59) Protein-rich diets 
produce inflammatory and toxic nitrogenous metabolites 
such as phenols, indoles, ammonia, and amines as results 
of microbial fermentation of undigested protein residues.
(60) The nitrogenous metabolites which are well-known 
potential carcinogens and a prominent risk factor of GI 
cancer are nitrosamine and nitrosamide, formed by the 
reaction of nitrosating agents, such as nitrite and secondary 
amines and amides. They are potent alkylating agents that 
induce GC to AT transitions at the second base of codon 12 
or 13 of the KRAS gene in the epithelial cells, then cause 
cancer development in the GI tract.(61,62)
 Figure 3 explain some probable mechanisms on the 
association between red/processed meat and colorectal 
carcinomabring out heme, NOCs, heterocyclic amines 
(HCAs), N-glycolylneuraminic acid (Neu5Gc) and PAHs 
which were contained in the red and processed meat to be 
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Figure 3.  Proposed schema 
showing the metabolism of 
dietary nitrate/nitrite and NOC 
formation in the gastrointestinal 
tract.(55) (Adapted with 
permission from Elsevier).
the carcinogenic mediators especially heme, although the 
exact mechanisms is still vague and controversial. Unless 
washed out by the gastric acid and antioxidant, red meat 
consumption can reach the lower intestine as precursors of 
nitrosating agents, together with bacterial formation from 
gut will modulate inflammation in the large intestine and by 
the time increased the cancer risk.(63) Multiple homeostatic 
signals especially Wnt signaling pathway regulate the 
homeostasis for normal colon epithelial architecture, the 
surface epithelial cells were controlled and well-balanced 
as well as new cells replacements from the crypts.(64,65) 
The key genes involved were known upregulated high heme 
ingestion.(66) Another evidence showed that heme iron 
induce G>A transition in adenomatous polyposis coli (APC) 
gene, rising 80% incident of the colon cancers considering 
APC is a tumor suppressor gene.(67,68) After the mutations, 
β-catenin accumulates within colonic epithelial cells and 
gets translocated to the nucleus, forming a complex with 
DNA binding factor T-cell factor. Further, this will lead to 
transcription factors activation promoting uncontrolled cell 
proliferation of the colonic epithelial crypts.(68) TP53 and 
KRAS were also known to be mutated with the presence of 
high heme. Moreover, heme leads to free radical formation 
and generation of DNA adducts in colorectal epithelial cells 
via lipid peroxidation. Intestinalk dysbiosis will promote 
heme carcinogenic properties. Anyhow, a balanced diet 
containing green vegetables, olive oil and calcium may 
reduce the heme’s carcinogenic effects.(69)
Chemoprevention: An Essential Approach to Controlling Cancer
Cancer can be defined as the dysregulated of cells 
proliferation. Many factors could induce cancers including 
environmental exposures (e.g., asbestos, ultraviolet 
radiation), lifestyle choices (tobacco, obesity, physical 
inactivity), infectious agents (e.g., human papillomavirus 
(HPV), human immunodeficiency virus (HIV), hepatitis 
B virus, Helicobacter pylori), and inherited conditions 
and mutations (e.g., familial adenomatous polyposis 
(FAP), hereditary nonpolyposis colorectal cancer, and the 
breast cancer (BRCA)1 and BRCA2). Chemoprevention 
termed as the use of drugs or other compounds to inhibit 
or reverse of the carcinogenic process.(70) Clinically, 
chemoprevention agents divided into three categories: 
primary chemoprevention (suited for they who may be at 
increased  risk  for  disease),  secondary  chemoprevention 
(for patients with premalignant lesions that may progress 
to an invasive disease), and tertiary chemoprevention (to 
prevent recurrence or second primary cancers disease in 
those individuals who have already endured potentially 
curative therapy, such as treatment with aromatase 
inhibitors).(71) Current primary chemoprevention agents 
including  nonsteroidal  antiinflammatory  drugs  (NSAIDs) 
(e.g., aspirin, sulindac, celecoxib), vitamins and their 
derivatives (e.g., retinoids, selenium, vitamin E), minerals 
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(e.g., calcium), and plant extracts (e.g., wheat bran fiber, tea 
catechins, flavonoids, berry extracts, curcumin).(15) 
 The failure to control cancer deaths from common 
epithelial malignancies, such as those that occur in the lung, 
breast, prostate, colon, pancreas and ovary, provides the 
ultimate rationale for an approach based on prevention. The 
logical approach to controlling cancer is to prevent it before 
the complex series of genetic and epigenetic events that 
result in invasive and metastatic malignancy have occurred.
(16) We need to refine our insights into early disease 
pathogenesis, together with enhanced screening for success 
risk assessment and any new risk models based on cellular 
and molecular insights.(15)
 Cancer chemoprevention refers to the use of agents 
for the inhibition, delay, or reversal of carcinogenesis before 
invasion. At the molecular level, cancer chemoprevention 
intended for disruption or at least delay the multiple 
pathways and processes among the three stages of 
carcinogenesis: initiation, promotion, and progression.
(72,73) Chemopreventive agents are referred as blocking 
agents since they block mutagenic interactions with DNA, 
either permanently evading damaged DNA by inactivating 
or metabolizing carcinogens directly, acting as free-radical 
scavengers, or physiologically inducing anti-oxidative 
enzyme activity and triggering mechanisms of DNA repair.
(73,74) Blocking agents can also modify the epigenomic 
landscape.(75) In the present review, agents examined in 
the context of cancer chemoprevention are classified in four 
major categories, which are hormonal, medications, diet-
related agents, and vaccines.(14) Because chemoprevention 
refers to the wide-spread and long-term use of compounds 
by the general healthy population, safety is an issue of 
paramount importance that needs to be addressed in studies 
with long follow-up in large segments of the population 
in order to be able to identify even rare side effects.(14) 
Chemoprevention will have to be taken for years, so ideally it 
should has little or no toxicity, with high efficacy in multiple 
sites, can be taken orally, low cost, and the mechanism of 
action is known.(18)
 On the contrary, suppressing agents refer to compounds 
that affect later stages of carcinogenesis (promotion and 
progression) by decreasing the proliferative capacity of 
initiated cells.(73) They hinder the proliferation of cancer 
cell by down-regulating signal transduction pathways 
such as NF-kB, mammalian target of rapamycin (mTOR), 
signal transducer and activator of transcription 3 (STAT-3), 
and many others (76-79), also by restraining enzymes that 
modulate signal transduction to hormone responsive elements 
such as cytochrome P450 (80). Suppressing agents are also 
likely to promote apoptosis pathways while inhibiting the 
angiogenesis, epithelial mesenchymal transition, invasion, 
and dissemination pathways thus reduce or delay the cells 
metastatic evolving ability, therefore decreasing the cancer 
mortality.(74,79-81)
 Based on epidemiological studies that people have 
lower incidence of cancer when they consume diet richer in 
fruits and vegetables, several chemoprevention molecules 
derived from spices, teas, fruits and vegetables including 
lemon, saffron, garlic, broccoli, pomegranate, berries, and 
others, suggested this happening due to all possible vitamins 
and other micronutrients, especially the antioxidant ones, 
such as vitamin A, C, and E, omega-3 fatty acids, and 
folate as in mediteranian diet.(39) Curcumin and green 
tea derived molecules showed their ability to stabilize 
IκB, the cytoplasmic inhibitor of NF-κB, so it cannot be 
translocated to the nucleus to act as a pro-inflammatory 
molecule, as we know that chronic inflammation associated 
with tumor progression as its role in ROS formation, lead 
to DNA alteration, promote several genes involved in cell 
proliferation for example via NF-κB.(82,83)
 Oxidative stress is not the only one to promote free 
radical scavenging but also some phytochemicals including 
sulphoraphane and resveratrol, derived from cruciferous 
vegetables such as broccoli and grapes in order. Nrf2, 
one transcription factor that acts as cell’s most important 
regulator of antioxidant defenses, binds to cis-enhancer 
sequences called antioxidant responsive elements that are 
5′-flanking of the promoter regions for genes encoding 
detoxifying and antioxidant enzymes, such as GST and 
NADPH:NQO1.(46,84,85) 
 Some phytochemical such as resveratrol, 
apigenin, curcumin, fisetin, quercetin, 6-gingerol, and 
piperlonguminine can either induce apoptosis or cell death 
through autophagy by different mechanisms.(86) Other 
studies exploit some phytochemicals to inhibit metastasis 
generation of tumor cells via epithelial mesenchymal 
transition. It was also found that silibinin, curcumin, green 
tea derived compounds, 6-gingerol, and resveratrol  could 
inhibit  matrix  metalloproteinases  (MMPs) expression, 
especially MMP-9, and in other side increasing  E-cadherin 
molecule,  that  maintain  the  cells to keep attached each 
other, make it more challenging for them to  migrate in 
adjacent tissue invasion.(87-89) Some phytochemicals 
supplement such as Protandim (Bacopa monniera, Camellia 
sinensis, Curcuma longa, Silybum marianum, and Withania 
somnifera)  showed  to  be  a  potent  activator  of  Nrf2 
in  both cell  culture  and  animal  models (74,90,91), 
while many are  also  known  to  inhibit  the  conversion 
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of  procarcinogens to their electrophilic (DNA damaging) 
species (17).
 Current studies showed that epigenetic was importantly 
involved in the progression of cancer as found in Table 1. 
Several epigenetic mechanisms relating to nucleosome 
organization including DNA methylation, histone 
post-translational modifications, such as methylation, 
acetylation, phosphorylation and nucleosomes occupancy 
Table 1.  Mechanism of action of the different bioactive compounds on epigenetic alterations.(18) (Adapted with permission from 
Frontiers Media).
dynamics have been described to be altered during cancer 
development.(92-94) They are potentially reversible 
count on environmental fluctuation such as nutrition, 
oxidative stress, pollution, inflammation, and life style.
(93,95) Therefore, epigenetic give a potential approach 
for cancer therapy. Currently, FDA approved the DNA 
methyltransferase (DNMT) inhibitors 5-azacytidine (5-
AZA) and 2′-deoxy-5-azacytidine (DAC) for the treatment 
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of myelodysplasia myelodysplastic syndrome (MDS), a 
preleukemic syndrome and myelomonocytic leukemia, 
and the results are promising too for solid tumor therapy.
(92,96,97) Epigenetics complementing the chemoprevention 
mechanisms, opening up the possibilities for new molecules 
findings, particularly to prevent the disease ad reach a better 
quality of life.(16)
Cruciferous Vegetable Intake and Risk of Cancer
Mostly healthy diets against chronic diseases including 
cancer recommend to increase vegetables and fruits 
consumption, as many growing evidences support that fruits 
and vegetables might be beneficial in cancer prevention.
(98,99) Cruciferous vegetables specifically, named for their 
cross-shaped flowers, including cabbage, broccoli, brussel’s 
sprouts, cauliflower and other members of the family, 
contain many nutrients with cancer-fighting properties. 
(100) Present meta-analysis studies representing a pooled 
total of 18,673 cases summarized the inverse associations 
between cruciferous vegetables consumption with risk of 
lung, colorectal, stomach, breast, prostate, and other cancers.
(101-111) About 200-250 g/day broccoli consumption for 10 
days has been showed to decrease tobacco smoke-induced 
DNA damage in smokers.(112,113) 
 The protective effect of cruciferous vegetables 
on breast cancer is biologically conceivable if we look 
deeper into their key components. Glucosinolates, the 
precursors of isothiocyanates (ITCs) and indole-3-carbinol 
believed to have anticancer properties,  are especially 
rich in cruciferous vegetables.(107) Previous study 
screened the extract of cruciferous vegetables and found 
that sulphoraphane [1-isothiocyanato-4-(methylsulfinyl)
butane].(85) A phytochemical belonging to a large chemical 
family of isothiocyanates, a potent antioxidant involving 
Nrf2 signaling and Aryl hydrocarbon receptor (Ahr) 
pathway.(114) By inhibition of phase I activating enzymes 
(e.g., cytochrome P450 (CYP)1A1 and CYP1A2), inhibits 
CYP1B1 in MCF10A cells (115), inhibits CYP3A4 in 
human hepatocytes (116). Induction of phase II detoxifying 
enzymes, such as GSTs, ITCs may protect cells against 
cancer initiation by neutralizing endogenous and exogenous 
electrophiles in breast tissue.(108,109) While indole-3-
carbinol induce 2-hydroxylation of estradiol, resulting in 
nonestrogenic metabolites (110), binding to the estrogen 
receptor (ER) thus downregulates the ER signaling and 
prevent the development of estrogen-related cancers 
including breast, endometrial and cervical cancers.
(102,111) Interestingly, the inverse association seems to 
be stronger for advanced stages of cancer. Current studies 
on isothiocyanates, including phenethyl isothiocyanate and 
sulforaphane, with addition of other chemicals from the 
same vegetables such as 3,3′-diindolylmethane, have been 
shown to inhibit prostate cancer cell growth and induction 
of apoptosis in vitro and in vivo by repression of androgen 
receptor and induction of endogenous cyclin-dependent 
kinase.(117-119) 
Cruciferous Vegetable Intake and Risk of Cancer
In modern advances of medical technology worldwide, in 
fact cancer cases keep growing.(120) Diet and exercises were 
known to significantly impact this prevalence, renewing 
interest in dietary phytochemical research, especially those 
including polyphenols, alkaloids, carotenoids, and nitrogen 
compounds.(121-124) These groups of phytochemicals 
showed the ability to affect cell proliferation and cell cycle 
regulation, involve in multiple signaling pathways that 
are often disrupted in tumor initiation, proliferation and 
propagation.(17,124-127)
 Carcinogenesis is a multistep process transforming a 
cell in its molecular level to undergo uncontrolled cellular 
division.(128) For the last fifty years, many research 
found innumerable critical molecular players and targeted 
pathways, which activate proto-oncogenes and inactivation 
of tumor suppressor genes, therefore cells represented 
tumor initiation, promotion and progression.(129,130) At 
initiation, after exposure to a carcinogenic agent, tumor 
cells start in a rapid and irreversible process, followed by 
its distribution and transportation to tissues causing non-
lethal  mutations  in  cellular  DNA.  The  accumulation  of 
this selective  clonal  initiated  cells  will  add  irreversible 
genetic changes which persist with each new cycle of 
proliferation.(130)
 Tumor promotion, in contrast, is a relatively lengthy 
and reversible process where actively proliferating pre-
neoplastic cells begin to divide and multiply as seen in Figure 
4.(131) Tumor progression, as the final stage, occurs after 
the mutations has reached an invasive cellular phenotype 
with metastatic potential.(130,132) Either dietary- and 
non-dietary-derived phytochemicals (molecules found in 
plants) cancer chemoprevention focusing on finding natural 
agents that specifically impact the earliest prevention of 
cellular transformation (protecting DNA from mutation) 
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Figure 4. Carcinogenesis is a multistep process that ultimately reprogram a normal cell into a cancer cell.(131) Adapted with 
permission from Impact Journals).
by modulation of cytoprotective enzyme activation.
(74,79,133-137) For example, phytochemicals agent that 
prevent carcinogens to reach its targeted sites, and at once 
support detoxification of highly reactive molecules.(134) 
Phytochemicals also enhance innate immune surveillance to 
eliminate transformed cells.(135) Finally, phytochemicals 
improve DNA repair mechanisms, tumor suppressors and 
inhibit cellular proliferation pathways.(133-137) As a 
primary chemoprevention, some phytochemicals appear to 
alter the epigenome and reverse abnormal gene expression 
through modulation of DNMTs, methyl binding proteins 
(MBDs), histone deacetylases (HDACs), micro RNAs 
(miRNAs), and several other epigenetic mechanisms. Thus, 
phytochemicals promote genomic integrity and cellular 
homeostasis in both in vitro and in vivo models.(75)
 Natural agents have emerged as novel therapeutic 
agents of drug-repositioning to influence autophagic 
activity.(138) Table 2 describes some natural agents and 
their mechanisms in cancer. Several natural agents modulate 
autophagy. For example, tanshinone IIA (139), ursolic acid 
(140), quercerin (141), fisetin (142), resveratrol (143), and 
honokiol (144) act as inhibitors of the AKT/ mTOR pathway. 
Tanshinone IIA modulates the initiation of phagophore 
formation. Ginsensoside (145) and ursolic acid (146) 
affect the formation of autophagosomes. Ginsenoside RO 
inhibits autophagosome-lysosome fusion.(147) Curcumin, 
or turmeric (bis-α, β-unsaturated β-diketone), is a gold-
colored spice widely used in Indian cooking, textile dyes, 
and in traditional Ayurvedic medicine I, contain polyphenol 
derived from the roots of the perennial Curcuma longa 
plant. Curcumin inhibits the growth of a variety of cell lines 
in vitro, by affecting the cell cycle arrest and apoptosis, 
specifically by modulating NF-κB, cyclooxygenase-2 
(COX-2), tumor necrosis factor alpha (TNF-α), STAT-3 and 
cyclin D1.(148-151)
 Resveratrol is a phytoalexin found in many fruits 
and plants including red wine, grapes, berries and peanuts.
(152) Highest levels of resveratrol found in the roots of 
the Polygonum cuspidatum, or Japanese knotweed, which 
is traditionally used as Chinese medicinal treatments for 
dermatitis, bacterial infections and inflammation. Previous 
studies identified the anti-cancer properties of resveratrol 
against several different tumor types in multiple stages. At 
higher dose, resveratrol could induce apoptosis and studies 
in rats showed resveratrol mediates a down-regulation 
of androgen receptor expression and suppression of 
androgen responsive glandular kallikrein, an orthologue 
of the human prostate specific antigen.(153-158) Another 
effects of resveratrol may be achieved through promoting 
innate immune system immunosurveillance and therefore 
enhancing elimination of spontaneous tumor cells prior to 
proliferation.(131)
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 Camellia sinensis, or tea, known as the most ancient 
and popular beverages consumed around the world. Different 
species of tea contains some combination of polyphenols, 
alkaloids, minerals, and other volatile organic compounds. 
(159) Epigallocatechin-3-gallate (EGCG) and Epicatechin-
3-gallate (ECG) found in a very high level in tea, especially 
higher in green tea.(160) Catechin polyphenols perform a 
strong antioxidant activity and thought to be able to prevent 
specific DNA damage by ROS, thereby preventing tumor 
mutagenesis of normal cells.(161,162) Tea polyphenols in 
pre-clinical studies showed to induce apoptosis and inhibit 
tumor cell growth, inhibit angiogenesis, modulating the 
immune system, and activating enzyme systems involved 
in cellular detoxification through the GST and quinone 
reductase pathways.(161,162)
 Endogenous antioxidants naturally produced in 
our body help to neutralize ROS, while external sources 
of antioxidants obtained from fruits, vegetables and 
grains.(129) Lycopene, beta carotene, Vitamins A, C, E, 
selenium and other dietary antioxidants known to prevent 
Natural Agents Cancer Preventing Mechanisms References
Tanshinone IIA, ursolic acid, quercerin, 
fisetin, resveratrol and honokiol
Inhibitors of the AKT/mTOR pathway (139-144)
Tanshinone IIA Modulates the initiation of phagophore formation (139)
Ginsensoside and ursolic acid Affect the formation of autophagosomes (145,146)
Ginsenoside Ro Inhibits autophagosome-lysosome fusion (147)
Curcumin, or turmeric (bis-α, β-
unsaturated β-diketone)
Inhibits the growth of a variety of cell lines in vitro , by affecting the cell 
cycle arrest and apoptosis, specifically by modulating 
NF-κB, COX-2,TNF-α, STAT-3 and cyclin D1
(148-151)
Resveratrol Induce apoptosis, promoting innate immune system immunosurveillance (153-158)
Epigallocatechin-3-gallate (EGCG) Induce apoptosis and inhibit tumor cell growth, inhibit angiogenesis, 
modulating the immune system, and activating enzyme systems involved 
in cellular detoxification through the glutathione S-transferase and 
quinone reductase pathways
(161,162)
Lycopene, beta carotene, Vitamins A, 
C, E, selenium
Prevent inflammation, preventing cellular damage induced by free ROS (163)
Folate, or folacin, pteroylglutamic acid 
or vitamin B9
Roles as a cofactor in carbon transfer reactions essential in DNA 
synthesis, repair and methylation
(164)
Apigenin (4′,5,7-trihydroxyflavone) Promoting cell cycle arrest and enhance apoptosis in cancer cells and 
xenograft models, downregulate NF-κB activity through the 
suppression of phosphorylation of p65, and Akt signaling, regulating 
Bcl-2, cyclin D1, cyclooxygenase-2, MMP-9 and NOS-2 expression 
in prostate carcinoma.
(175-177,180)
Table 2. Some natural agents’ chemo-preventive mechanism.
inflammation, preventing cellular damage induced by free 
ROS, thus slow the cancer development.(163)
 Folate, or folacin, pteroylglutamic acid or vitamin 
B9, is a water-solute B-vitamin. Folate roles as a cofactor 
in carbon transfer reactions essential in DNA synthesis, 
repair and methylation.(164)  Humans can not synthesize 
folates  de novo, so we take folic acid supplements. Large 
prospective studies showed ~25% reduction in colorectal 
cancer risk in subjects who takes high folate compared to 
ones with lower intake (165), and a meta analysis study 
reported a significant reduction in breast cancer risk in 
women who take higher folate in their diet although no 
correlation was found  between  circulating  folate  level 
and  breast  cancer risk (166).
 Lycopene is a natural carotenoid found in many fruits 
and vegetables especially in tomatoes and its derivative 
products.(167) Recent studies showed that lycopene 
involved in antioxidant reactions including SOD-1 and 
GST-omega-1 thus downregulate ROS expression, and ROS 
generating proteins.(168) Another study pointed lycopene 
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to inhibit cell proliferation, induce apoptosis, and attenuate 
the  metastatic  capacity  of  prostate  cancer  cells (169,170), 
as supported by the data that linked increased consumption 
of  lycopene-rich  food  with  lower  prostate  cancer  risks 
(170-172).
 Apigenin (4′,5,7-trihydroxyflavone), also abundant in 
fruits and vegetables, is a kind of flavonoid with a broad 
spectrum of anti-proliferative activities against many cancer 
cells.(173,174) Several proposed mechanisms of apigenin 
reported its role in promoting cell cycle arrest and enhance 
apoptosis in cancer cells and xenograft models (175,176), 
downregulate NF-κB activity through the suppression 
of phosphorylation of p65 (177), and Akt signaling (178-
179). Apigenin exerted potent chemopreventive activities 
through regulating B-cell lymphoma 2 (BCL-2), cyclin 
D1, cyclooxygenase-2, MMP-9 and NOS-2 expression in 
prostate carcinoma.(180) 
Conclusion
Many studies provide the role of red meat and processed 
meat in colorectal, esophagus, liver, kidney, and prostate 
cancer, which etiology mechanisms suggested by means 
of HCAs, polycyclic PAHs, NOCs, and heme iron. On the 
contrary, several dietary agents clearly shown to have anti-
cancer properties and contribute as one variable affecting 
the cancer prevalence. However, understanding how these 
dietary agents interact with cancer cells, the immune system 
and oxidative stress pathways may one day expose a way 
of safe, pleasant, non-toxic and economical anti-cancer 
therapeutics.
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